National Health Surveillance Agency
The National Health Surveillance Agency (in Portuguese, Agência Nacional de Vigilância Sanitária, ANVISA) is a regulatory body of the Brazilian government. It has a role similar to that of the FDA in the United States, is responsible for the regulation and approval of pharmaceutical drugs, sanitary standards and regulation of the food industry.
The agency bills itself as "an independently administered, financially autonomous" regulatory body that offers "security of tenure" for its five-member Collegiate Board of Directors during their mandate periods.[1]
References
- ↑ "ANVISA's official website in English". Archived from the original on 2013-02-16.
See also
- Similar agencies
- Public Health Agency of Canada (PHAC;
Canada) - Chinese Center for Disease Control and Prevention (CCDC;
People's Republic of China) - European Centre for Disease Prevention and Control (ECDC)
European Union - Institut de veille sanitaire (IVS)
France - Robert Koch Institute, Federal Institute for Risk Assessment (
Germany) - Hellenic Centre for Diseases Control and Prevention (
Greece) - Centre for Health Protection (CHP)
Hong Kong - National Centre for Disease Control (
India) - Istituto Superiore di Sanità (ISS;
Italy) - Norwegian Institute of Public Health (FHI;
Norway) - Health Protection Agency (HPA;
United Kingdom) - Centers for Disease Control and Prevention (CDC)
United States
- Public Health Agency of Canada (PHAC;
- Epidemic Intelligence Service
- World Health Organization (WHO;
United Nations)
This article is issued from Wikipedia - version of the Wednesday, December 30, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.